Email this article Fundoplication as prophylaxis of reflux-esophagitis in patients with varicose esophageal veins
- Authors: Vasnev O.S.1, Yanova O.B.1, Kovyazina I.O.1, Vasnev OS2, Yanova OB2, Kovyazina IO2
-
Affiliations:
- Central Research Institute of Gastroenterology, Moscow
- Issue: Vol 83, No 2 (2011)
- Pages: 9-12
- Section: Editorial
- URL: https://ter-arkhiv.ru/0040-3660/article/view/30788
- ID: 30788
Cite item
Full Text
Abstract
Material and methods. EM was examined in 100 patients (64 males and 36 females aged 33-74 years, mean age 52.8±5.7 years) with hepatic cirrhosis (HC). Of them, 80 patients have undergone endoscopic ligation of the esophageal veins, 20 patients - surgical disconnection of the azigoportal blood flow according to the original method with additional fundoplication. All the patients had intrahepatic portal hypertension caused by HC of different etiology.
Results. Before operation, 70% patients had inflammation-induced alterations of the EM of different severity. Endoscopic ligation of the esophageal veins did not change the rate of EM inflammation detection. In operated patients reflux-esophagitis was detected significantly less frequently.
Conclusion. The above results show efficacy of fundoplication as a method of esophagitis prevention. Esophagitis is one of VEV hemorrhage risk factors. Fundoplication is not easy to make and is not indicated for all HC patients, especially in urgent situations. However, in case of decision to operate for prevention of VEV hemorrhage, it is advisable to conduct fundoplication.
About the authors
Oleg Sergeevich Vasnev
Email: o. vasnev@rambler.ru
Oksana Borisovna Yanova
Inna Olegovna Kovyazina
O S Vasnev
Central Research Institute of Gastroenterology, MoscowCentral Research Institute of Gastroenterology, Moscow
O B Yanova
Central Research Institute of Gastroenterology, MoscowCentral Research Institute of Gastroenterology, Moscow
I O Kovyazina
Central Research Institute of Gastroenterology, MoscowCentral Research Institute of Gastroenterology, Moscow
References
- Шерлок Ш., Дули Дж. Заболевания печени и желчевыводящих путей. Практическое руководство: Пер. с англ. М.: ГЭОТАР-МЕД; 1999.
- Фуркало С. Н., Кондратюк В. А. Портальная гипертензия: современные интервенционные методики лечения. Мiстецво Лiкуванняю 2004; 6: 11.
- Franchis R. Evolving Consensus in Portal Hypertension Report of the Baveno IV Consensus Workshop on methodology of diagnosis and therapy in portal hypertension. J. Hepatol. 2005; 43 (1): 167-176.
- Надинская М. Ю. Печеночная энцефалопатия. В кн.: Ивашкин В. Т. (ред.). Болезни печени и желчевыводящих путей. М.: М-Вести; 2002.
- Franchis R. Updating consensus in portal hypertension: report of the Baveno III consensus workshop on definitions, methodology and therapeutic strategies in portal hypertension. J Hepatol. 2000; 33: 846-852.
- Lui H. F., Stanley A. J., Forrest E. H. et al. Primary prophylaxis of variceal hemorrhage: a randomized controlled trial comparing band ligation, propranolol, and isosorbide mononitrate. Gastroenterology 2002; 123 (3): 735-744.
- Sarin S. K., Lahoti D., Saxena S. P. et al. Prevalence, classification and natural history of gastric varices. Hepatology 1992; 16: 1343-1349.
- McCormack G., McCormick P. A. A practical guide to the management of oesophageal varices. Drugs 1999; 57 (3): 327- 335.
- Оноприев В. И., Дурлештер В. М., Усова О. А., Ключников О. Ю. Хирургическое лечение кровотечений из варикозно-расширенных вен пищевода и желудка. Хирургия 2005; 1: 38-42.
- Калинин А. В. Симптоматические гастродуоденальные язвы. Клинические лекции по гастроэнтерологии и гепатологии. М.: Государственный институт усовершенствования врачей МО РФ, Главный военный клинический госпиталь им. Н. Н. Бурденко; 2002; 1: 283-304.
- Demirturk L., Yazgan Y., Izci O. et al. The effect of Helicobacter pylori eradication on gastric juice and blood ammonia concentrations and on visual evoked potentials in cirrhotics. Helicobacter 2001; 6 (4): 325-330.
- Буткевич Е. И., Подопригорова В. Г., Снапковский Н. И. Кислотообразующая функция желудка у больных хроническими диффузными заболеваниями печени. Рос. журн. гастроэнтерол., гепатол., колопроктол. 2002; 12 (1): 59.
- Hoyumpa A. M., Treino-Alanis H., Grimes I. et al. Rabeprazole: pharmacokinetics in patients with stable compensated cirrhosis. Clin. Ther. 1999; 4: 691-701.
- Лазебник Л. Б., Чекмазов И. А., Васнев О. С. Способ хирургического лечения варикозного расширения вен пищевода и кардиального отдела желудка. Пат. на изобретение № 2285459; Россия, 2006.
Supplementary files
